NNC0519-0130
A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine
Novo Nordisk · Phase 1 · Completed · Enrollment 46
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Part 1a: NNC0519-0130 C and NNC0519-0130 B | n/r | n/r | n/r | n/r |
| Part 1b: NNC0519-0130 B and NNC0519-0130 C | n/r | n/r | n/r | n/r |
| Part 2a: NNC0519-0130 B and NNC0519-0130 C | n/r | n/r | n/r | n/r |
| Part 2b: NNC0519-0130 C and NNC0519-0130 B | n/r | n/r | n/r | n/r |
Not shown
- Part 1a: NNC0519-0130 C and NNC0519-0130 B: endpoint not reported
- Part 1b: NNC0519-0130 B and NNC0519-0130 C: endpoint not reported
- Part 2a: NNC0519-0130 B and NNC0519-0130 C: endpoint not reported
- Part 2b: NNC0519-0130 C and NNC0519-0130 B: endpoint not reported